KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stereotaxis (STXS) Raw Materials (2016 - 2025)

Stereotaxis (STXS) has disclosed Raw Materials for 15 consecutive years, with $6.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Raw Materials rose 12.64% to $6.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $6.7 million, a 12.64% increase, with the full-year FY2024 number at $5.2 million, down 11.74% from a year prior.
  • Raw Materials was $6.7 million for Q3 2025 at Stereotaxis, up from $6.5 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $7.8 million in Q1 2023 to a low of $2.9 million in Q1 2021.
  • A 5-year average of $5.6 million and a median of $6.0 million in 2024 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: tumbled 33.49% in 2021, then skyrocketed 109.2% in 2022.
  • Stereotaxis' Raw Materials stood at $3.6 million in 2021, then skyrocketed by 80.01% to $6.6 million in 2022, then decreased by 9.73% to $5.9 million in 2023, then fell by 11.74% to $5.2 million in 2024, then rose by 28.83% to $6.7 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's Raw Materials are $6.7 million (Q3 2025), $6.5 million (Q2 2025), and $6.0 million (Q1 2025).